SCHEMBL13469162

SCHEMBL13469162

CNC(=O)c1cccc(=O)n1O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDH1 O75874 4/20 0.70
MMP1 P03956 1/20 0.51
MMP3 P08254 1/20 0.51
MMP7 P09237 1/20 0.51
MMP9 P14780 1/20 0.51
MMP8 P22894 1/20 0.51
MMP12 P39900 1/20 0.51
MMP13 P45452 1/20 0.51
HDAC8 Q9BY41 5/20 0.43
HDAC6 Q9UBN7 5/20 0.43
HDAC4 P56524 3/20 0.41
HDAC7 Q8WUI4 3/20 0.41
HDAC9 Q9UKV0 3/20 0.41
HDAC5 Q9UQL6 3/20 0.41
HDAC2 Q92769 2/20 0.39
PLK1 P53350 1/20 0.38
BRD4 O60885 3/20 0.37
BRD2 P25440 1/20 0.36
BRD3 Q15059 1/20 0.36
BRDT Q58F21 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18427362 0.80 IDH1 (0.64) IDH1MMP1MMP3MMP7MMP9
SCHEMBL23153390 0.80 IDH1 (0.64) IDH1MMP1MMP3MMP7MMP9
SCHEMBL13024178 0.79 IDH1 (0.62) IDH1MMP1MMP3MMP7MMP9
SCHEMBL13531433 0.78 IDH1 (0.66) IDH1MMP1MMP3MMP7MMP9
SCHEMBL22852019 0.78 IDH1 (0.66) IDH1MMP1MMP3MMP7MMP9
SCHEMBL19978233 0.78 IDH1 (0.60) IDH1MMP1MMP3MMP7MMP9
SCHEMBL17770632 0.77 IDH1 (0.59) IDH1MMP1MMP3MMP7MMP9
SCHEMBL13469336 0.77 IDH1 (0.64) IDH1MMP1MMP3MMP7MMP9
SCHEMBL13469343 0.77 IDH1 (0.64) IDH1MMP1MMP3MMP7MMP9
SCHEMBL38651963 0.77 IDH1 (0.64) IDH1MMP1MMP3MMP7MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018048879-A1 METAL CHELATORS FOR IMAGING, THERAPEUTICS, AND BIOANALYSIS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2018-03-15 WO disclosed
US-20170298272-A1 LIGAND-SENSITIZED LANTHANIDE NANOCRYSTALS AS ULTRAVIOLET DOWNCONVERTERS ENERGY, UNITED STATES DEPARTMENT OF 2017-10-19 US disclosed
US-9556122-B2 Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-01-31 US disclosed
US-9556122-B2 Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-01-31 US disclosed
US-20140039169-A1 LUMINESCENT 1-HYDROXY-2-PYRIDINONE CHELATES OF LANTHANIDES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2014-02-06 US disclosed
US-8557601-B2 Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-10-15 US disclosed
EP-2511266-A1 Luminescent 1-Hydroxy-2-Pyridinone Chelates of Lanthanides The Regents of The University of California (US) 2012-10-17 EP disclosed
US-20100015725-A1 LUMINESCENT 1-HYDROXY-2-PYRIDINONE CHELATES OF LANTHANIDES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-01-21 US disclosed
WO-2008008797-A2 LUMINESCENT 1-HYDROXY-2-PYRIDINONE CHELATES OF LANTHANIDES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-01-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140039169-A1 LUMINESCENT 1-HYDROXY-2-PYRIDINONE CHELATES OF LANTHANIDES PLPBP, HPD, LASP1 IDH1 25/4885MMP1 945/4885MMP3 1614/4885
US-20100015725-A1 LUMINESCENT 1-HYDROXY-2-PYRIDINONE CHELATES OF LANTHANIDES PLPBP, HPD, LASP1 IDH1 25/4885MMP1 945/4885MMP3 1614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.